ITCI.Intra-cellular Therapies, INC

Form 4: Intra-Cellular Therapies CEO Exercises Stock Options, Reports Beneficial Ownership

Sentiment:

SEC Form 4 Filing

📋All filings for Intra-cellular Therapies, INC
🔒Login to Follow

Sharon Mates, Chairman and CEO of Intra-Cellular Therapies, Inc., reports exercising stock options and changes in beneficial ownership.

Summary

  • On April 24, 2024, Sharon Mates, the Chairman and CEO of Intra-Cellular Therapies, Inc., executed transactions involving stock options.
  • Mates exercised options to acquire 8,638 shares at $16.86 per share and 11,382 shares at $17.57 per share.
  • Following these transactions, Mates directly owns 1,070,329 shares of Intra-Cellular Therapies, Inc.
  • The exercised options were granted on June 30, 2014, and January 2, 2015, and were fully vested.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock option exercises, which is neutral in sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors monitor these filings for insights into management's perspective on the company's stock.

Stakeholder Impact

  • The transaction may have a minor impact on shareholders due to the change in the number of outstanding shares.

Key Dates

DateDescription
June 30, 2014Grant date of stock option with exercise price of $16.86 per share.
January 2, 2015Grant date of stock option with exercise price of $17.57 per share.
April 24, 2024Date of stock option exercise.
April 25, 2024Date of Form 4 filing.
June 30, 2024Expiration date of stock option granted on June 30, 2014.
January 2, 2025Expiration date of stock option granted on January 2, 2015.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.